JOHN KIRKWOOD to Indazoles
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Indazoles.
Connection Strength
0.182
-
Targeting the MAPK pathway in advanced BRAF wild-type melanoma. Ann Oncol. 2019 04 01; 30(4):503-505.
Score: 0.150
-
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Oncotarget. 2017 Mar 07; 8(10):16367-16386.
Score: 0.032